Spark Biomedical, Inc., a leader in wearable neurostimulation technology, announced today that its FDA-cleared Sparrow Ascent™ device for opioid withdrawal symptom relief will now be distributed within select Department of Veterans Affairs facilities through a partnership with electroCore, Inc., a commercial-stage bioelectronic medicine company.
